KeraVet Bio, Inc., announced today that it has completed a controlled clinical study that shows that pet parents overwhelmingly prefer using KeraVet Gel to an Elizabethan collar (otherwise known as the cone or E-collar). This study is a follow-up to the randomized controlled clinical study KeraVet Bio completed that showed that the KeraVet Gel product significantly reduced licking behavior and improved healing outcomes (publication in review at the American Journal of Veterinary Research).
Tag: Clinical Study
A GPS for the Gastrointestinal System
The MoPill system represents a significant leap forward in how we can diagnose and treat gastrointestinal conditions.
First Patient Dosed in Phase 2 Clinical Study of Palatin’s Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that patient dosing has started for the clinical study entitled: BMT-801: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Clinical Study Investigating the Safety, Tolerability, and Effectiveness of the Co-Administration of Bremelanotide with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity (ClinicalTrials.gov Identifier: NCT06565611).
Preliminary Data Support Novel Immunotherapy for Advanced Malignant Melanoma in Dogs
A clinical study of 11 dogs with advanced malignant melanoma demonstrated the efficacy, safety, and tolerability profile of cANK-101, a canine interleukin-12 anchored immunotherapy.
THE GORE RELIEF CLINICAL STUDY BEGINS RANDOMIZING PATIENTS TO EVALUATE PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF
The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of patent foramen ovale (PFO) with the GORE® CARDIOFORM Septal Occluder for the relief of migraine headaches.
University of Miami serving as pilot study site for new, rapid coronavirus breathalyzer test
By participating in a short clinical research study that begins this week, the University of Miami became the first college testing site for a quick, easy, and cost-effective Israeli-produced COVID-19 Breath Analyzer that could revolutionize coronavirus testing if approved by the U.S. Food and Drug Administration (FDA).
Loyola Medicine Study Explores Hypnotherapy for Gastrointestinal Issues
Loyola Medicine is among the first to conduct a clinical study using hypnotherapy to treat functional dyspepsia, a gastrointestinal disorder affecting approximately 10 percent of the population.